European Consensus on the evaluation of women presenting with excessive hair growth

European Journal of Dermatology

Volumn 19, Issue 6, 2009, Pages 597-602

  Blume Peytavi, Ulrike ^a   Atkin, Stephen ^b   Shapiro, Jerry ^c   Lavery, Stuart ^d   Grimalt, Ramon ^e   Hoffmann, Rolf ^f   Gieler, Uwe ^g   Messenger, Andrew ^h  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BARCELONA   (Spain)

^f Privatpraxis   (Germany)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

^h ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Evaluation; Hirsutism; Unwanted facial hair

Indexed keywords

PROLACTIN; TESTOSTERONE;

ANAMNESIS; ANDROGEN SYNTHESIS; ARTICLE; BODY MASS; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PRACTICE; CONSENSUS; DISEASE ASSOCIATION; DRUG USE; ECHOGRAPHY; ETHNICITY; EUROPE; FEMALE; HAIR GROWTH; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HIRSUTISM; HUMAN; HYPERANDROGENISM; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; OBESITY; ONSET AGE; OVARY POLYCYSTIC DISEASE; PATIENT CARE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREMENOPAUSE; PROFESSIONAL KNOWLEDGE; PROLACTIN BLOOD LEVEL; PSYCHOSOMATICS; QUALITY OF LIFE; SKIN COLOR; SKINFOLD THICKNESS; TESTOSTERONE BLOOD LEVEL; THYROID FUNCTION;

EUROPEAN UNION; EVIDENCE-BASED MEDICINE; FEMALE; HIRSUTISM; HUMANS; INTERNATIONAL COOPERATION; MEDICAL RECORDS; PREMENOPAUSE; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 73249150521     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2009.0786     Document Type: Article

References (49)

1. Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med 2005; 353: 2578-88.
2. Trueb RM. Causes and management of hypertrichosis. Am J Clin Dermatol 2002; 3: 617-27.
3. Nikolaou D, Gilling-Smith C. Hirsutism. Curr Obstet Gynaecol 2005; 15: 174-83.
4. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol 1994; 41: 231-6.
5. Morán C, Tapia MC, Hernández E, Vázquez G, García-Hernández E, Bermúdez JA. Etiologic review of hirsutism in 250 patients. Arch Med Res 1994; 25: 311-4.
6. Sanchez LA, Knochenhauer ES, Gatlin R, et al. Differential diagnosis of clinically evident hyperandrogenism: Experience with over 1000 consecutive patients. Fertil Steril 2001; 76: S111 [abstract].
7. Waggoner W, Boots LR, Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: A populational study. Gynecol Endocrinol 1999; 13: 1-7.
8. Carmina E, Rosato F, Janni A, Rizzo M, Longo R. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006; 91: 2-6.
9. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002. Obstet Gynecol 2002; 100: 1389-402.
10. Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am 2005; 34: 677-705.
11. Goodman NF, Bledsoe MB, Cobin RH, et al. American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract 2001; 7: 120-34.
12. Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003; 101: 995-1007.
13. Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1105-20.
14. Barth JH, Catalan J, Cherry CA, Day A. Psychological morbidity in women referred for treatment of hirsutism. J Psychosom Res 1993; 37: 615-9.
15. Hahn S, Janssen OE, Tan S, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrino 2005; 153: 853-60.
16. Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M. Quality of life of hirsute women. Postgrad Med J 1993; 69: 186-9.
17. NICE Guidelines: Core interventions in the treatment of obsessive-compulsive disorder and body dimorphic disorder. 2005; http://guidance.nice.org.uk/CG31/quickrefguide/pdf/English.
18. Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2008: 13.
19. Codner E, Cassoria F. Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm Res 2009; 71: 12-21.
20. Camacho-Martinez FM. Hypertrichosis. In: Blume-Peytavi U, Tosti A, Whiting DA, Trüeb R, eds. Hair Growth and Disorders. Springer 1. Edition, 2008: 333-53.
21. Wijeyaratne CN, Balen AH, Barth JH. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) 2002; 57: 343-50.
22. Carey AH, Chan KL, Short F, White D, Williamson R, Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 1993; 38: 653-8.
23. Goodarzi MO, Shah NA, Antoine HJ, Pall M, Guo X, Azziz R. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab 2006; 91: 4085-91.
24. Hahn S, Fingerhut A, Khomtsiv U, et al. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with poycystic ovary syndrome. Clin Endocrinol (Oxf) 2005; 62: 573-9.
25. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-36.
26. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.
27. Joseph-Horne R, Mason H, Batty S, et al. Luteal phase progesterone excretion in ovulatory women with polycystic ovaries. Hum Reprod 2002; 17: 1459-63.
28. Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R. The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol 2004; 191: 1914-20.
29. Rigopoulos D, Georgala S. Pathogenesis of hirsutism. In: Camacho FM, Randall VA, Price VH, eds. Hair and its disorders: biology, pathology and management. London: Martin Dunitz, 2000: 33-5.
30. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000; 21: 347-62.
31. Reingold SB, Rosenfield RL. The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol 1987; 123: 209-12.
32. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992; 327: 157-62.
33. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988; 1: 870-2.
34. Glintborg D, Hermann AP, Brusgaard K, Hangaard J, Hagen C, Andersen M. Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab 2005; 90: 1347-53.
35. Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR. Idiopathic hirsutism: An uncommon cause of hirsutism in Alabama. Fertil Steril 1998; 70: 274-8.
36. Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol 1998; 139: 421-3.
37. Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol 1983; 147: 90-101.
38. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-8.
39. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815-30.
40. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83: 1717-23.
41. Hahn S, Kuehnel W, Tan S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med 2007; 45: 202-7.
42. Sowers M, Derby C, Jannausch ML, Torrens JI, Pasternak R. Insulin Resistance, Hemostatic Factors, and Hormone Interactions in Preand Perimenopausal Women: SWAN. J Clin Endocrinol Metab 2003; 88: 4904-10.
43. Escobar-Morreale HF, Asuncion M, Calvo RM, Sancho J, San Millan JL. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 2001; 145: 619-24.
44. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453-62.
45. Wild RA, Umstot ES, Andersen RN, Ranney GB, Givens JR. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol 1983; 146: 602-6.
46. Rittmaster RS. Hirsutism. Lancet 1997; 349: 191-5.
47. Sathyapalan T, Atkin SL. Rational testing: Investigating hirsutism. Br Med J 2009 in press.
48. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000; 88: 711-36.
49. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2005; 83: 1343-6.